Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4096719 | 1.00 | SMN1; SMN2 (0.34) | SMN1; SMN2KMT2ACA14 | |
| SCHEMBL31324714 | 1.00 | SMN1; SMN2 (0.34) | SMN1; SMN2KMT2ACA14 | |
| SCHEMBL30240854 | 1.00 | SMN1; SMN2 (0.34) | SMN1; SMN2KMT2ACA14 | |
| SCHEMBL933475 | 1.00 | SMN1; SMN2 (0.34) | SMN1; SMN2KMT2ACA14 | |
| SCHEMBL31649022 | 1.00 | SMN1; SMN2 (0.34) | SMN1; SMN2KMT2ACA14 | |
| SCHEMBL31324738 | 1.00 | SMN1; SMN2 (0.34) | SMN1; SMN2KMT2ACA14 | |
| SCHEMBL31324778 | 1.00 | SMN1; SMN2 (0.34) | SMN1; SMN2KMT2ACA14 | |
| SCHEMBL31324781 | 1.00 | SMN1; SMN2 (0.34) | SMN1; SMN2KMT2ACA14 | |
| SCHEMBL29865581 | 1.00 | SMN1; SMN2 (0.34) | SMN1; SMN2KMT2ACA14 | |
| SCHEMBL10632304 | 0.98 | SMN1; SMN2 (0.33) | SMN1; SMN2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112043855-B | Carrier for atomized essence, preparation method of carrier and atomized essence | 深圳昱朋科技有限公司 | 2022-02-15 | — | — | CN | claimed |
| CN-112043855-A | Carrier for atomized essence, preparation method of carrier and atomized essence | 深圳昱朋科技有限公司 | 2020-12-08 | — | — | CN | claimed |
| CN-106279318-B | The separation method and flavone composition of flavone compound in calamint | 中国医学科学院药用植物研究所 | 2019-05-03 | — | — | CN | claimed |
| EP-2797942-B1 | COMPOSITION OF NOVEL CARBOHYDRATE DRUG FOR TREATMENT OF HUMAN DISEASES | GALECTIN THERAPEUTICS INC (US) | 2018-10-31 | — | — | EP | claimed |
| EP-2906227-B1 | GALACTOSE-PRONGED CARBOHYDRATE COMPOUNDS FOR THE TREATMENT OF DIABETIC NEPHROPATHY AND ASSOCIATED DISORDERS | GALECTIN THERAPEUTICS INC (US) | 2018-10-03 | — | — | EP | claimed |
| CN-108129530-A | Detect substrate of β-D-Glucose aldehyde neuraminidase and preparation method thereof and kit | 广东优尼德生物科技有限公司 | 2018-06-08 | — | — | CN | claimed |
| CN-106727508-A | A kind of combination drug for treating chronic dysentery | 郑州掌盟网络科技有限公司 | 2017-05-31 | — | — | CN | claimed |
| CN-106581025-A | Composite western medicine for treating chronic dysentery | 郑州仁宏医药科技有限公司 | 2017-04-26 | — | — | CN | claimed |
| CN-106511440-A | Compound Chinese and Western medicine composition for treating chronic dysentery and preparation method thereof | 郑州仁宏医药科技有限公司 | 2017-03-22 | — | — | CN | claimed |
| EP-4044822-B1 | CHOCOLATE PRODUCTS, INGREDIENTS, PROCESSES AND USES | NESTLE SA (CH) | 2024-05-15 | — | — | EP | disclosed |
| US-20240099326-A1 | CHOCOLATE PRODUCTS, INGREDIENTS, PROCESSES AND USES | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2024-03-28 | — | — | US | disclosed |
| CN-116670296-A | Method for producing sugar products and fermentation products | 维尔萨利斯股份公司 | 2023-08-29 | — | — | CN | disclosed |
| CN-116333187-A | Preparation and application of hundred methyl-esterified pectin in banana pulp | 中国热带农业科学院分析测试中心 | 2023-06-27 | — | — | CN | disclosed |
| US-11447759-B2 | Carbohydrate degrading polypeptide and uses thereof | DSM IP ASSETS B.V. (NL) | 2022-09-20 | — | — | US | disclosed |
| CN-103374049-A | Method for preparing 5,6,4'-trihydroxy flavone-7-0-D-glucuronic acid | KUNMING PHARMACEUTICAL GROUP | 2013-10-30 | — | — | CN | disclosed |
| CN-102625704-A | N-sulfate oligosaccharides activating fibroblast growth factor receptors, their preparation, and their therapeutic use | SANOFI SA | 2012-08-01 | — | — | CN | disclosed |
| CN-102574931-A | FGF receptor-activating N-acyl octasaccharides, preparation thereof, and therapeutic use thereof | SANOFI AVENTIS | 2012-07-11 | — | — | CN | disclosed |
| CN-1135223-C | Aryl-substd. propanolamine derivs., method for their production, medicaments contg. said compounds and their use | ���ĵ�˹ҩ��¹�����˾ | 2004-01-21 | — | — | CN | disclosed |
| CN-1409724-A | Estradiol conjugates and uses thereof | CLIPTOFAMA PTY LTD (AU) | 2003-04-09 | — | — | CN | disclosed |
| CN-1321148-A | Aryl-substd. propanolamine derivs., method for their production, medicaments contg. said compounds and their use | AVENTIS PHARMA GMBH (DE) | 2001-11-07 | — | — | CN | disclosed |